285 related articles for article (PubMed ID: 18288311)
1. Testicular dysgenesis syndrome and the estrogen hypothesis: a quantitative meta-analysis.
Martin OV; Shialis T; Lester JN; Scrimshaw MD; Boobis AR; Voulvoulis N
Environ Health Perspect; 2008 Feb; 116(2):149-57. PubMed ID: 18288311
[TBL] [Abstract][Full Text] [Related]
2. Testicular dysgenesis syndrome and the estrogen hypothesis: a quantitative meta-analysis.
Martin O; Shialis T; Lester J; Scrimshaw M; Boobis A; Voulvoulis N
Cien Saude Colet; 2008; 13(5):1601-18. PubMed ID: 18813661
[TBL] [Abstract][Full Text] [Related]
3. Association between testicular dysgenesis syndrome (TDS) and testicular neoplasia: evidence from 20 adult patients with signs of maldevelopment of the testis.
Skakkebaek NE; Holm M; Hoei-Hansen C; Jørgensen N; Rajpert-De Meyts E
APMIS; 2003 Jan; 111(1):1-9; discussion 9-11. PubMed ID: 12752226
[TBL] [Abstract][Full Text] [Related]
4. Testicular dysgenesis syndrome comprises some but not all cases of hypospadias and impaired spermatogenesis.
Jørgensen N; Rajpert-De Meyts E; Main KM; Skakkebaek NE
Int J Androl; 2010 Apr; 33(2):298-303. PubMed ID: 20132348
[TBL] [Abstract][Full Text] [Related]
5. Cryptorchidism and hypospadias as a sign of testicular dysgenesis syndrome (TDS): environmental connection.
Toppari J; Virtanen HE; Main KM; Skakkebaek NE
Birth Defects Res A Clin Mol Teratol; 2010 Oct; 88(10):910-9. PubMed ID: 20865786
[TBL] [Abstract][Full Text] [Related]
6. Testicular dysgenesis syndrome: possible role of endocrine disrupters.
Bay K; Asklund C; Skakkebaek NE; Andersson AM
Best Pract Res Clin Endocrinol Metab; 2006 Mar; 20(1):77-90. PubMed ID: 16522521
[TBL] [Abstract][Full Text] [Related]
7. Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects.
Sharpe RM; Skakkebaek NE
Fertil Steril; 2008 Feb; 89(2 Suppl):e33-8. PubMed ID: 18308057
[TBL] [Abstract][Full Text] [Related]
8. Association of diethylstilbestrol exposure in utero with cryptorchidism, testicular hypoplasia and semen abnormalities.
Gill WB; Schumacher GF; Bibbo M; Straus FH; Schoenberg HW
J Urol; 1979 Jul; 122(1):36-9. PubMed ID: 37351
[TBL] [Abstract][Full Text] [Related]
9. Testicular dysgenesis syndrome: foetal origin of adult reproductive problems.
Wohlfahrt-Veje C; Main KM; Skakkebaek NE
Clin Endocrinol (Oxf); 2009 Oct; 71(4):459-65. PubMed ID: 19222487
[TBL] [Abstract][Full Text] [Related]
10. In utero exposure to di(n-butyl) phthalate and testicular dysgenesis: comparison of fetal and adult end points and their dose sensitivity.
Mahood IK; Scott HM; Brown R; Hallmark N; Walker M; Sharpe RM
Environ Health Perspect; 2007 Dec; 115 Suppl 1(Suppl 1):55-61. PubMed ID: 18174951
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor alpha is a major contributor to estrogen-mediated fetal testis dysgenesis and cryptorchidism.
Cederroth CR; Schaad O; Descombes P; Chambon P; Vassalli JD; Nef S
Endocrinology; 2007 Nov; 148(11):5507-19. PubMed ID: 17673513
[TBL] [Abstract][Full Text] [Related]
12. Male reproductive disorders in humans and prenatal indicators of estrogen exposure. A review of published epidemiological studies.
Storgaard L; Bonde JP; Olsen J
Reprod Toxicol; 2006 Jan; 21(1):4-15. PubMed ID: 16005180
[TBL] [Abstract][Full Text] [Related]
13. Human 'testicular dysgenesis syndrome': a possible model using in-utero exposure of the rat to dibutyl phthalate.
Fisher JS; Macpherson S; Marchetti N; Sharpe RM
Hum Reprod; 2003 Jul; 18(7):1383-94. PubMed ID: 12832361
[TBL] [Abstract][Full Text] [Related]
14. Testicular dysgenesis syndrome and the development and occurrence of male reproductive disorders.
Virtanen HE; Rajpert-De Meyts E; Main KM; Skakkebaek NE; Toppari J
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):501-5. PubMed ID: 16005920
[TBL] [Abstract][Full Text] [Related]
15. Are estrogens carcinogenic during development of the testes?
McLachlan JA; Newbold RR; Li S; Negishi M
APMIS; 1998 Jan; 106(1):240-2; discussion 243-4. PubMed ID: 9524585
[TBL] [Abstract][Full Text] [Related]
16. The epidemiologic evidence linking prenatal and postnatal exposure to endocrine disrupting chemicals with male reproductive disorders: a systematic review and meta-analysis.
Bonde JP; Flachs EM; Rimborg S; Glazer CH; Giwercman A; Ramlau-Hansen CH; Hougaard KS; Høyer BB; Hærvig KK; Petersen SB; Rylander L; Specht IO; Toft G; Bräuner EV
Hum Reprod Update; 2016 Dec; 23(1):104-125. PubMed ID: 27655588
[TBL] [Abstract][Full Text] [Related]
17. Does a testicular dysgenesis syndrome exist?
Akre O; Richiardi L
Hum Reprod; 2009 Sep; 24(9):2053-60. PubMed ID: 19443456
[TBL] [Abstract][Full Text] [Related]
18. The 'oestrogen hypothesis'- where do we stand now?
Sharpe RM
Int J Androl; 2003 Feb; 26(1):2-15. PubMed ID: 12534932
[TBL] [Abstract][Full Text] [Related]
19. Testicular dysgenesis syndrome.
Skakkebaek NE
Horm Res; 2003; 60 Suppl 3():49. PubMed ID: 14671395
[TBL] [Abstract][Full Text] [Related]
20. Environment, testicular dysgenesis and carcinoma in situ testis.
Olesen IA; Sonne SB; Hoei-Hansen CE; Rajpert-De Meyts E; Skakkebaek NE
Best Pract Res Clin Endocrinol Metab; 2007 Sep; 21(3):462-78. PubMed ID: 17875492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]